Difference between revisions of "Eluvixtamab (AMG-330)"
Jump to navigation
Jump to search
(Created page with "=Mechanism of action= Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3 Category:Investigational Category:Antibody medications") |
Warner-admin (talk | contribs) m (Text replacement - "/CD3 bispecific" to "-CD3 bispecific") |
||
(19 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
− | =Mechanism of action= | + | ==Mechanism of action== |
− | Bispecific T-cell engager | + | Bispecific T-cell engager antibody that engages CD33 and CD3 |
− | + | ==Also known as== | |
+ | *'''Code name:''' AMG-330 | ||
− | [[Category: | + | [[Category:Drugs]] |
+ | |||
+ | [[Category:Intravenous medications]] | ||
+ | |||
+ | [[Category:T-cell activators]] | ||
+ | [[Category:Anti-CD33-CD3 bispecific antibodies]] | ||
+ | |||
+ | [[Category:Investigational drugs]] |
Latest revision as of 00:14, 18 October 2023
Mechanism of action
Bispecific T-cell engager antibody that engages CD33 and CD3
Also known as
- Code name: AMG-330